Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Collegium Pharmaceutical (AllerNaze)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

AllerNaze is a intra-nasal steroid product. The AllerNaze nasal spray is used in treating nasal itching, sneezing and nasal congestion in patients with allergic rhinitis.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 780 Dedham Street
  • Suite 800
  • Canton, ME 02021
  • United States

Collegium Pharmaceutical (AllerNaze) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Collegium Pharmaceutical (AllerNaze)‘s full profile, request access.

Request full access to PitchBook

Collegium Pharmaceutical (AllerNaze) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Collegium Pharmaceutical (AllerNaze)‘s full profile, request access.

Request full access to PitchBook